Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
about
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic miceThe cellular proteins that bind specifically to the Epstein-Barr virus origin of plasmid DNA replication belong to a gene familyEpstein-Barr virus microRNAs are evolutionarily conserved and differentially expressedLessons from rare tumors: hepatic lymphoepithelioma-like carcinomasMechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting.The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveRedefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell linesEstablishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID miceProtein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virusEpstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.The role of EBV in post-transplant malignancies: a review.Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus.Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection.The expression and function of Epstein-Barr virus encoded latent genesIdentification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infectionEpstein-Barr virus-associated lymphomas.Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.Structural analyses of the Epstein-Barr virus BamHI A transcriptsEpstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latencyA subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 proteinMolecular genetic analysis of Epstein-Barr virus Cp promoter functionActivation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycleThe Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsHost-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programsThe latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.Epstein-Barr virus-induced epigenetic alterations following transient infection.Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure.Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
P2860
Q24562912-FA1AAD9B-3ACF-4014-965F-8BE617B8F392Q24563778-A0D1F40F-1032-4C58-919E-66AB7C13EF9FQ25257225-1F534D80-2F78-470F-B263-91454BE7D987Q28087354-0AC0C430-3456-4F6B-BD49-BC1D54C3654AQ33653017-7A585526-F06F-4CF8-AE74-62C55D82AF93Q33657311-2ECA89FA-A3AB-42FF-9EBE-2AB8E2599370Q33783746-E8630FB0-EA69-4DE4-A963-C5BEC0C58241Q33784685-048E1D84-855A-4293-A1A4-AA43A85FAA35Q33784983-BAC16140-12E4-47AB-A65E-EDBBF106F49EQ33865166-924B077F-88CE-4757-ACAE-EAF8C3F7C964Q33911843-118B4199-A8CF-4001-A85B-7C8FC02E054AQ33925488-CB1A5158-987D-41AF-890E-3F3264BF7F0AQ33965965-EABCAE48-2652-4A7A-A27D-84C4B7822729Q34064290-7B6B34A8-6C81-4079-A161-2A21C5464F7AQ34089485-3AE0A30B-E66D-4DFC-B0DB-565024343496Q34353305-64DA844C-4F41-46B9-9C1D-7FE0A9DFABCAQ34651670-65589DBD-1669-4CD8-946B-249637670461Q35764932-6485407B-9FF3-4450-BB98-F17A4A78FA04Q35798521-9C109F96-3A09-4ED5-8A42-770D9F688C5BQ35829364-4925BEA4-5866-4FAC-89A2-C135C30AAEF6Q35832657-724ABD02-47BB-4525-A45D-2B324B340F11Q35833217-7543B342-B334-4EB3-B091-5DB076236060Q35839956-869F8724-66A4-4816-81EC-AF579491E92EQ35854017-D23D61C7-5676-4637-A69A-6E40E3AD9577Q35856784-92C523A4-5331-491B-9261-204BC6265BC8Q35859223-7EB8ABAB-CA78-4AEE-BF6A-AF752E03C5A6Q35861192-D37675C3-834E-4E3F-8038-63C0BBC319A8Q35872919-D85CA293-847D-4D3B-8B31-0CC55F1CDFFEQ35874869-40696FDB-75E3-4E74-AEA2-BB8B6415E6F5Q36135900-70D98754-C1E7-4CB4-AF5E-33ED24224298Q36564877-4481822E-7E85-42FF-8DD9-5A6C54628CEBQ36622842-3B83C7AA-ADB7-461E-AC8D-BD85738EE5D0Q36625981-BBBA63D8-23DC-4E95-B9DF-256971DBE326Q36637195-CD878ABB-5EC6-45CF-9E75-E283571D93C1Q36651288-A8220579-FF0D-4BF8-AD52-3D554DDFEF5EQ36653989-23E86FDB-8FBB-4AF1-AD2A-D56E89545E54Q36655826-2A3D872C-3F17-4448-A34B-A24C4BCA5B87Q36668946-BA1A9F82-DEBD-4876-80E5-5DE0A08EF697Q36687455-5DE21257-DAED-4C80-A7B8-38C13BF9D4F0Q36696963-0BF4FE3E-435B-46F7-BC79-D3CA7F5A14AC
P2860
Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Restricted Epstein-Barr virus ...... anscriptional initiation site.
@en
Restricted Epstein-Barr virus ...... anscriptional initiation site.
@nl
type
label
Restricted Epstein-Barr virus ...... anscriptional initiation site.
@en
Restricted Epstein-Barr virus ...... anscriptional initiation site.
@nl
prefLabel
Restricted Epstein-Barr virus ...... anscriptional initiation site.
@en
Restricted Epstein-Barr virus ...... anscriptional initiation site.
@nl
P2093
P2860
P356
P1476
Restricted Epstein-Barr virus ...... anscriptional initiation site.
@en
P2093
P2860
P304
P356
10.1073/PNAS.88.14.6343
P407
P577
1991-07-01T00:00:00Z